Insider Transactions in Q4 2022 at Utah Medical Products Inc (UTMD)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
           
            Dec 06                          
            2022                          
           
         |           
        Brian Koopman Principal Financial Officer | 
           
              BUY
             
            
                Exercise of conversion of derivative security
             
           | 
        Direct | 
           
              500
              +33.51%
              
         |   
        
           
              $37,000              
              $74.64 P/Share              
                     
         | 
      
| 
           
            Dec 06                          
            2022                          
           
         |           
        Brian Koopman Principal Financial Officer | 
           
              SELL
             
            
                Payment of exercise price or tax liability
             
           | 
        Direct | 
           
              366
              -42.66%
              
         |   
        
           
              $36,966              
              $101.88 P/Share              
                     
         | 
      
| 
           
            Nov 18                          
            2022                          
           
         |           
        Paul O Richins Director | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Indirect | 
           
              449
              -1.97%
              
         |   
        
           
              $40,410              
              $90.81 P/Share              
                     
         | 
      
| 
           
            Nov 17                          
            2022                          
           
         |           
        Paul O Richins Director | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Indirect | 
           
              161
              -0.7%
              
         |   
        
           
              $14,490              
              $90.0 P/Share              
                     
         | 
      
| 
           
            Nov 11                          
            2022                          
           
         |           
        Paul O Richins Director | 
           
              SELL
             
            
                Open market or private sale
             
           | 
        Indirect | 
           
              40
              -0.17%
              
         |   
        
           
              $3,680              
              $92.5 P/Share              
                     
         | 
      
| 
           
            Oct 31                          
            2022                          
           
         |           
        Brian Koopman Principal Financial Officer | 
           
              SELL
             
            
                Bona fide gift
             
           | 
        Direct | 
           
              65
              -7.04%
              
         |   
        
           
              $5,720              
              $88.94 P/Share              
                     
         |